First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model

INTRODUCTION: We have identified structural determinants on tau protein that are essential for pathological tau–tau interaction in Alzheimer’s disease (AD). These regulatory domains, revealed by monoclonal antibody DC8E8, represent a novel target for tau-directed therapy. In order to validate this t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kontsekova, Eva, Zilka, Norbert, Kovacech, Branislav, Novak, Petr, Novak, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255368/
https://www.ncbi.nlm.nih.gov/pubmed/25478017
http://dx.doi.org/10.1186/alzrt278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255368/
https://www.ncbi.nlm.nih.gov/pubmed/25478017
http://dx.doi.org/10.1186/alzrt278

Ejemplares similares